Literature DB >> 2502538

Induction of ermC methylase in the absence of macrolide antibiotics and by pseudomonic acid A.

S K Kadam1.   

Abstract

The methylase encoded by erm genes and induced by erythromycin modifies the 23S rRNA and confers resistance to macrolide-lincosamide-streptogramin B antibiotics. Induction is due to a posttranscriptional mechanism in which the inducer activates translation of methylase mRNA by binding to unmethylated (erythromycin-sensitive) ribosomes and stalling them in the leader region. It is shown in this study that pseudomonic acid A, an inhibitor of isoleucyl-tRNA synthetase, can also induce methylase synthesis. Isoleucine starvation has a similar effect on ribosomes translating the ermC leader region to cause induction of methylase synthesis. These observations support the requirements for ribosome stalling and destabilization of a stem-loop structure and demonstrate that stalling can occur without macrolide-bound ribosomes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502538      PMCID: PMC210237          DOI: 10.1128/jb.171.8.4518-4520.1989

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Characterization of plasmid transformation in Bacillus subtilis: kinetic properties and the effect of DNA conformation.

Authors:  S Contente; D Dubnau
Journal:  Mol Gen Genet       Date:  1979-01-02

2.  Erythromycin, a peptidyltransferase effector.

Authors:  J C Mao; E E Robishaw
Journal:  Biochemistry       Date:  1972-12-05       Impact factor: 3.162

Review 3.  Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.

Authors:  D Dubnau
Journal:  CRC Crit Rev Biochem       Date:  1984

4.  Demonstration of erythromycin-dependent stalling of ribosomes on the ermC leader transcript.

Authors:  C S Narayanan; D Dubnau
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

5.  Chloramphenicol-inducible gene expression in Bacillus subtilis.

Authors:  E J Duvall; D M Williams; P S Lovett; C Rudolph; N Vasantha; M Guyer
Journal:  Gene       Date:  1983-10       Impact factor: 3.688

6.  Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes.

Authors:  J R Menninger; D P Otto
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  Posttranscriptional regulation of an erythromycin resistance protein specified by plasmic pE194.

Authors:  A G Shivakumar; J Hahn; G Grandi; Y Kozlov; D Dubnau
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

Review 8.  Chloramphenicol acetyltransferase: enzymology and molecular biology.

Authors:  W V Shaw
Journal:  CRC Crit Rev Biochem       Date:  1983

9.  Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance.

Authors:  S Horinouchi; B Weisblum
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Induction of macrolide-lincosamide-streptogramin B resistance requires ribosomes able to bind inducer.

Authors:  T J Gryczan; M Israeli-Reches; D Dubnau
Journal:  Mol Gen Genet       Date:  1984
View more
  4 in total

Review 1.  Ribosome regulation by the nascent peptide.

Authors:  P S Lovett; E J Rogers
Journal:  Microbiol Rev       Date:  1996-06

Review 2.  Insights into erythromycin action from studies of its activity as inducer of resistance.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 3.  Nascent peptide regulation of translation.

Authors:  P S Lovett
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

4.  Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis.

Authors:  J H Kwak; E C Choi; B Weisblum
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.